A retrospective study evaluates the use of antibiotic lock therapy as a catheter-sparing strategy in pediatric patients with hematologic and oncologic diseases.

A preliminary injunction preserves higher federal student loan limits for eligible NP and PA students while litigation continues.

Backed by phase 3 PATINA trial data, Ibrance is the first and only CDK4/6 inhibitor available for HR+ metastatic disease across all HER2 patient profiles.

Investigators assessed whether machine learning models provide accurate, individualized risk predictions for major 30-day postoperative complications following glossectomy.

The shortages trace to manufacturing problems, shipping delays and decisions by some companies to stop making the medicines, according to the U.S. Food and Drug Administration (FDA).

The new presentation is expected to provide an additional self-administration option for patients with polycythemia vera.

Median DFS was not reached in group receiving aglatimagene plus valacyclovir followed by EBRT after median follow-up of 50.3 months.

West Health and Gallup drew on self-reported experiences from nationally representative surveys to categorize individuals into 1 of 3 groups based on their ability to afford and access needed care.

New research suggests structured skin care improves the quality of life for patients with cancer by managing common treatment-related skin toxicities.

Investigators analyzed how participation in the Oncology Care Model affected treatment initiation for patients with poor-prognosis cancers.

A multicenter randomized clinical trial evaluates the impact of an app-facilitated digital symptom monitoring strategy with nurse-led follow-up on health-related quality of life and hospital ...

Researchers calculated potential savings on high-cost cancer medications if access to MFN prices negotiated by Medicare was expanded.